Clinical Efficacy of Remicade in Chronic Beryllium Disease: A Randomized, Double-Blind, Placebo-Controlled, Investigator Initiated Trial.

Trial Profile

Clinical Efficacy of Remicade in Chronic Beryllium Disease: A Randomized, Double-Blind, Placebo-Controlled, Investigator Initiated Trial.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 10 Jun 2016

At a glance

  • Drugs Infliximab (Primary)
  • Indications Pneumoconiosis
  • Focus Therapeutic Use
  • Acronyms BISCIT
  • Most Recent Events

    • 24 Sep 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
    • 18 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top